At Proven Connect, we believe that accelerating innovation is the key to transforming outcomes for men with prostate cancer. We do this by investing early in promising biotech companies and supporting them with expertise and patient-driven insight to help bring life-changing treatments to the clinic.

This month, PCR has launched its Summer Appeal to help fuel the next wave of pioneering investments that Proven Connect will make on behalf of patients.

Through Proven Connect, PCR is putting innovation at the heart of its mission to drive real change for people living with prostate cancer. Every pound raised through the Summer Appeal is an investment in a future where men have more treatment options, more hope, and better outcomes — faster.

To find out more or to support the appeal: Boost the chances of uncovering crucial breakthroughs